INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis

BIT:1ISRG • US46120E6023

410.85 EUR
-57.35 (-12.25%)
Last: Feb 5, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

7

Overall 1ISRG gets a fundamental rating of 7 out of 10. We evaluated 1ISRG against 65 industry peers in the Health Care Equipment & Supplies industry. 1ISRG scores excellent points on both the profitability and health parts. This is a solid base for a good stock. 1ISRG is valued quite expensive, but it does show an excellent growth. These ratings would make 1ISRG suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year 1ISRG was profitable.
  • In the past year 1ISRG had a positive cash flow from operations.
  • Each year in the past 5 years 1ISRG has been profitable.
  • Each year in the past 5 years 1ISRG had a positive operating cash flow.
1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 13.96%, 1ISRG belongs to the top of the industry, outperforming 92.19% of the companies in the same industry.
  • 1ISRG has a better Return On Equity (16.02%) than 84.38% of its industry peers.
  • The Return On Invested Capital of 1ISRG (13.95%) is better than 90.63% of its industry peers.
  • 1ISRG had an Average Return On Invested Capital over the past 3 years of 12.43%. This is above the industry average of 9.73%.
  • The last Return On Invested Capital (13.95%) for 1ISRG is above the 3 year average (12.43%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROIC 13.95%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
1ISRG.MI Yearly ROA, ROE, ROIC1ISRG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 28.38%, 1ISRG belongs to the top of the industry, outperforming 96.88% of the companies in the same industry.
  • 1ISRG's Profit Margin has improved in the last couple of years.
  • 1ISRG's Operating Margin of 29.35% is amongst the best of the industry. 1ISRG outperforms 98.44% of its industry peers.
  • In the last couple of years the Operating Margin of 1ISRG has grown nicely.
  • Looking at the Gross Margin, with a value of 66.00%, 1ISRG is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • 1ISRG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.35%
PM (TTM) 28.38%
GM 66%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
1ISRG.MI Yearly Profit, Operating, Gross Margins1ISRG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1ISRG is still creating some value.
  • Compared to 1 year ago, 1ISRG has less shares outstanding
  • Compared to 5 years ago, 1ISRG has more shares outstanding
  • There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1ISRG.MI Yearly Shares Outstanding1ISRG.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ISRG.MI Yearly Total Debt VS Total Assets1ISRG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • An Altman-Z score of 41.32 indicates that 1ISRG is not in any danger for bankruptcy at the moment.
  • 1ISRG has a better Altman-Z score (41.32) than 98.44% of its industry peers.
  • 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 41.32
ROIC/WACC1.44
WACC9.7%
1ISRG.MI Yearly LT Debt VS Equity VS FCF1ISRG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • A Current Ratio of 4.87 indicates that 1ISRG has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.87, 1ISRG belongs to the top of the industry, outperforming 96.88% of the companies in the same industry.
  • A Quick Ratio of 3.96 indicates that 1ISRG has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.96, 1ISRG belongs to the best of the industry, outperforming 95.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.87
Quick Ratio 3.96
1ISRG.MI Yearly Current Assets VS Current Liabilites1ISRG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • 1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.83%, which is quite impressive.
  • The Earnings Per Share has been growing by 21.42% on average over the past years. This is a very strong growth
  • Looking at the last year, 1ISRG shows a very strong growth in Revenue. The Revenue has grown by 20.51%.
  • The Revenue has been growing by 18.22% on average over the past years. This is quite good.
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%

3.2 Future

  • Based on estimates for the next years, 1ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.00% on average per year.
  • Based on estimates for the next years, 1ISRG will show a quite strong growth in Revenue. The Revenue will grow by 12.91% on average per year.
EPS Next Y14.46%
EPS Next 2Y14.31%
EPS Next 3Y14.59%
EPS Next 5Y14%
Revenue Next Year15.92%
Revenue Next 2Y14.87%
Revenue Next 3Y14.63%
Revenue Next 5Y12.91%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1ISRG.MI Yearly Revenue VS Estimates1ISRG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
1ISRG.MI Yearly EPS VS Estimates1ISRG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 54.56, 1ISRG can be considered very expensive at the moment.
  • 1ISRG's Price/Earnings ratio is in line with the industry average.
  • 1ISRG's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.98.
  • With a Price/Forward Earnings ratio of 47.68, 1ISRG can be considered very expensive at the moment.
  • 1ISRG's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 1ISRG is more expensive than 68.75% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of 1ISRG to the average of the S&P500 Index (28.01), we can say 1ISRG is valued expensively.
Industry RankSector Rank
PE 54.56
Fwd PE 47.68
1ISRG.MI Price Earnings VS Forward Price Earnings1ISRG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 65.63% of the companies listed in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as 1ISRG.
Industry RankSector Rank
P/FCF 69.49
EV/EBITDA 45.27
1ISRG.MI Per share data1ISRG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of 1ISRG may justify a higher PE ratio.
  • 1ISRG's earnings are expected to grow with 14.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.77
PEG (5Y)2.55
EPS Next 2Y14.31%
EPS Next 3Y14.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for 1ISRG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INTUITIVE SURGICAL INC

BIT:1ISRG (2/5/2026, 7:00:00 PM)

410.85

-57.35 (-12.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-20
Inst Owners88.29%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap145.91B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts78.1
Price Target533.94 (29.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)4.89%
PT rev (3m)2.43%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)0.31%
EPS NY rev (1m)3%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.53%
Revenue NY rev (1m)1.01%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE 54.56
Fwd PE 47.68
P/S 17.2
P/FCF 69.49
P/OCF 57.11
P/B 9.71
P/tB 9.93
EV/EBITDA 45.27
EPS(TTM)7.53
EY1.83%
EPS(NY)8.62
Fwd EY2.1%
FCF(TTM)5.91
FCFY1.44%
OCF(TTM)7.19
OCFY1.75%
SpS23.89
BVpS42.31
TBVpS41.39
PEG (NY)3.77
PEG (5Y)2.55
Graham Number84.67
Profitability
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROCE 16.01%
ROIC 13.95%
ROICexc 20.73%
ROICexgc 21.4%
OM 29.35%
PM (TTM) 28.38%
GM 66%
FCFM 24.75%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 79.72%
Cap/Sales 5.36%
Interest Coverage 250
Cash Conversion 83.46%
Profit Quality 87.21%
Current Ratio 4.87
Quick Ratio 3.96
Altman-Z 41.32
F-Score8
WACC9.7%
ROIC/WACC1.44
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
EPS Next Y14.46%
EPS Next 2Y14.31%
EPS Next 3Y14.59%
EPS Next 5Y14%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%
Revenue Next Year15.92%
Revenue Next 2Y14.87%
Revenue Next 3Y14.63%
Revenue Next 5Y12.91%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year34.54%
EBIT Next 3Y22.15%
EBIT Next 5Y17.41%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%

INTUITIVE SURGICAL INC / 1ISRG.MI FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 5 / 10 to 1ISRG.MI.


What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?

ChartMill assigns a valuation rating of 1 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.


Can you provide the profitability details for INTUITIVE SURGICAL INC?

INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for 1ISRG stock?

The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 54.56 and the Price/Book (PB) ratio is 9.71.


Can you provide the financial health for 1ISRG stock?

The financial health rating of INTUITIVE SURGICAL INC (1ISRG.MI) is 7 / 10.